期刊文献+

Qualitative and Quantitative Analysis for the Quality Control of Rhizoma Coptidis by HPLC-DAD and HPLC-ESI-MS 被引量:1

Qualitative and Quantitative Analysis for the Quality Control of Rhizoma Coptidis by HPLC-DAD and HPLC-ESI-MS
下载PDF
导出
摘要 For quality control purpose, an approach of fingerprinting and simultaneous quantification of five major bioactive constituents of Rhizoma Coptidis was established via a high-performance liquid chromatograph coupled with a photodiode array UV detector(HPLC-DAD) and an electrospray ionization mass spectrometer(HPLC-ESI/MS) The compounds were identified on the basis of the comparison of their mass spectra with literature data and those of standard samples and quantified by the HPLC-DAD method. Baseline separation was achieved on an XTerra C18 column(5 μm, 250 mm×4.6 mm i. d.) with linear gradient elution of formate buffer(consisting of 0.5% formic acid, adjusted to pH=4.5 with ammonia) and acetonitrile(consisting of 0.2% formic acid and 0.2% triethylamine). The me- thod was validated for linearity(r^2〉0.9995), repeatability(RSD〈3.1%), intra- and inter-day precision(RSD〈1.8%) with recovery(99.9%-105.1%), limits of detection(0.15-0.35 μg/mL), and limits of quantification(0.53-0.82 μg/mL). The similarities of 32 batches of Rhizoma Coptidis and their classification according to their manufacturers were based on the retention time and peak areas of the characteristic compounds. The five compounds were selected for quality assessment ofRhizoma coptidis via partial least squares analysis(PLS). For quality control purpose, an approach of fingerprinting and simultaneous quantification of five major bioactive constituents of Rhizoma Coptidis was established via a high-performance liquid chromatograph coupled with a photodiode array UV detector(HPLC-DAD) and an electrospray ionization mass spectrometer(HPLC-ESI/MS) The compounds were identified on the basis of the comparison of their mass spectra with literature data and those of standard samples and quantified by the HPLC-DAD method. Baseline separation was achieved on an XTerra C18 column(5 μm, 250 mm×4.6 mm i. d.) with linear gradient elution of formate buffer(consisting of 0.5% formic acid, adjusted to pH=4.5 with ammonia) and acetonitrile(consisting of 0.2% formic acid and 0.2% triethylamine). The me- thod was validated for linearity(r^2〉0.9995), repeatability(RSD〈3.1%), intra- and inter-day precision(RSD〈1.8%) with recovery(99.9%-105.1%), limits of detection(0.15-0.35 μg/mL), and limits of quantification(0.53-0.82 μg/mL). The similarities of 32 batches of Rhizoma Coptidis and their classification according to their manufacturers were based on the retention time and peak areas of the characteristic compounds. The five compounds were selected for quality assessment ofRhizoma coptidis via partial least squares analysis(PLS).
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2010年第5期735-741,共7页 高等学校化学研究(英文版)
基金 Supported by the National Natural Science Foundation of China(No.30725045) Shanghai Leading Academic Discipline Project (No.B906) in part by the Scientific Foundation of Shanghai China(Nos.07DZ19728, 06DZ19717 and 06DZ19005)
关键词 Rhizoma Coptidis HPLC-DAD HPLC-MS Partial least squares analysis Quality control Rhizoma Coptidis HPLC-DAD HPLC-MS Partial least squares analysis Quality control
  • 相关文献

参考文献22

  • 1China Pharmacopoeia Committee, China Pharmacopoeia, Vol. 1, Chemical Industry Press, Beijing, 2005, A213.
  • 2Lee D. U., Kang Y. J., Park M. K., Lee Y. S., Seo H. G., Kim T. S., Kim C. H., Chang K. C., Life. Sci., 2003, 73, 1401.
  • 3Enk R., Ehehalt R., Graham J. E., Bierhaus A., Remppis A., Greten H. J., Graham A., .Z Ethnopharm., 2007, 109, 170.
  • 4Yu H. H., Kim K. J., Cha J. D., Kim H. K., Lee Y. E., Choi N. Y., You Y. O., J. Med. Food, 2005, 8, 454.
  • 5Hwang J. M., Kuo H. C., Tseng T. H., Liu J. Y., Chu C. Y., Arch. Toxicol., 2006, 80, 62.
  • 6Hsu W. H., Hsieh Y. S., Kuo H. C., Teng C. Y., Huang H. I., Wang C. J., Yang S. F., Liou Y. S., Kuo W. H., Arch. Toxicol., 2007, 81, 719.
  • 7World Health Organization, Guidelines for the Assessment of Herbal Medicines, Munich, WHO, Geneva, 1991, 286.
  • 8Dumarey M., van Nederkassel A. M., Deconinck E., van der Heyden Y., J. Chromatogr. A, 2008, 1192, 81.
  • 9Bartolome L., Deusto M., Etxebarria N., Navarro P., Usobiaga A., Zuloaga O., J. Chromatogr. A, 2007, 1157, 369.
  • 10Kang J., Zhou L., Sun J., Han J., Guo D. A., J. Pharm. Biomed. Anal., 2008, 47, 778.

同被引文献21

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部